(Q28740885)

English

H1-antihistamine up-dosing in chronic spontaneous urticaria: patients' perspective of effectiveness and side effects--a retrospective survey study

scientific article (publication date: 2011)

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

0 references

H1-antihistamine up-dosing in chronic spontaneous urticaria: patients' perspective of effectiveness and side effects--a retrospective survey study (English)

0 references

histamine antagonist

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

chronic spontaneous urticaria

1 reference

based on heuristic

inferred from title

Sabine Altrichter

object named as

Sabine Altrichter

7

0 references

Frank Siebenhaar

object named as

Frank Siebenhaar

5

0 references

9

object named as

Marcus Maurer

0 references

author name string

Karsten Weller

1

0 references

Claudia Ziege

2

0 references

Petra Staubach

3

0 references

Knut Brockow

4

0 references

Karoline Krause

6

0 references

Martin K Church

8

0 references

language of work or name

0 references

publication date

2011

0 references

0 references

6

0 references

9

0 references

e23931

0 references

copyright license

Creative Commons Attribution 4.0 International

1 September 2011

1 reference

April 2022 Public Data File from Crossref

copyright status

0 references

The extent and nature of disability in different urticarial conditions

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3164658

17 March 2017

Fexofenadine in higher doses in chronic spontaneous urticaria

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3164658

3 June 2018

Unmet clinical needs in chronic spontaneous urticaria. A GA²LEN task force report

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3164658

3 June 2018

The effectiveness of levocetirizine and desloratadine in up to 4 times conventional doses in difficult-to-treat urticaria.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3164658

3 June 2018

Risk of first-generation H(1)-antihistamines: a GA(2)LEN position paper

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3164658

3 June 2018

EAACI/GA(2)LEN/EDF/WAO guideline: management of urticaria

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3164658

3 June 2018

EAACI/GA(2)LEN/EDF/WAO guideline: definition, classification and diagnosis of urticaria

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3164658

3 June 2018

High-dose desloratadine decreases wheal volume and improves cold provocation thresholds compared with standard-dose treatment in patients with acquired cold urticaria: a randomized, placebo-controlled, crossover study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3164658

3 June 2018

Clinical pharmacokinetics and pharmacodynamics of desloratadine, fexofenadine and levocetirizine : a comparative review

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3164658

3 June 2018

Advances in H1-antihistamines

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3164658

3 June 2018

Antihistamines and driving ability: evidence from on-the-road driving studies during normal traffic

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3164658

3 June 2018

Tolerance to daytime sedative effects of H1 antihistamines

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3164658

3 June 2018

H1-receptor antagonists: safety issues

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3164658

3 June 2018

H1-receptor antagonists. Comparative tolerability and safety

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3164658

3 June 2018

Clinical and laboratory parameters in predicting chronic urticaria duration: a prospective study of 139 patients

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0023931

21 January 2018

Double-blind crossover study of high-dose cetirizine in cholinergic urticaria.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0023931

21 January 2018

The use of a responder analysis to identify clinically meaningful differences in chronic urticaria patients following placebo- controlled treatment with rupatadine 10 and 20 mg.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0023931

21 January 2018

Rupatadine and its effects on symptom control, stimulation time, and temperature thresholds in patients with acquired cold urticaria.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0023931

21 January 2018

Clinical pharmacology of H1-antihistamines in the skin

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0023931

21 January 2018

Chronic urticaria: an internet survey of health behaviours, symptom patterns and treatment needs in European adult patients

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0023931

21 January 2018

The natural history of chronic urticaria and angioedema in patients visiting a tertiary referral centre

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0023931

21 January 2018

The impact of chronic urticaria on the quality of life.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3164658

27 November 2018

Increasing the dose of cetirizine may lead to better control of chronic idiopathic urticaria: an open study of 21 patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/21909407

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Chronic unremitting urticaria: is the use of antihistamines above the licensed dose effective? A preliminary study of cetirizine at licensed and above-licensed doses

1 reference

https://pubmed.ncbi.nlm.nih.gov/21909407

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparative study of the impact of chronic urticaria, psoriasis and atopic dermatitis on the quality of life

1 reference

https://pubmed.ncbi.nlm.nih.gov/21909407

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1371/JOURNAL.PONE.0023931

0 references

2011PLoSO...623931W

0 references

PMC publication ID

0 references

PubMed publication ID

0 references

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q28740885&oldid=1868903206"